Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cassava Sciences Inc
(NQ:
SAVA
)
11.12
-0.43 (-3.72%)
Streaming Delayed Price
Updated: 1:49 PM EDT, Jul 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cassava Sciences Inc
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
3 Healthcare Stocks to Sell in July Before They Crash & Burn
July 08, 2024
Many healthcare names are attractive. But drugstore chains and some drug makers have poor outlooks. Here are three healthcare stocks to sell.
Via
InvestorPlace
Top 5 Health Care Stocks That May Explode In July
July 08, 2024
Via
Benzinga
3 Biotech Stocks to Sell in July Before They Crash & Burn
July 05, 2024
While biotech stocks have potential to provide high returns, they are often overly dependent on drug approvals. Sell these before its too late
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
July 01, 2024
Via
Benzinga
Why Cassava Sciences Stock Is Sinking Today
July 01, 2024
The biotech stock is feeling the heat from an indictment of a former consultant.
Via
The Motley Fool
Peering Into Cassava Sciences's Recent Short Interest
May 17, 2024
Via
Benzinga
(SAVA) - Analyzing Cassava Sciences's Short Interest
March 21, 2024
Via
Benzinga
Cassava Sciences: Q4 Earnings Insights
February 28, 2024
Via
Benzinga
Is There Any Hope for Cassava Sciences Stock?
February 03, 2024
Battered by controversy, this company will need to show real results to prosper.
Via
The Motley Fool
Planet Labs Layoffs 2024: What to Know About the Latest Planet Job Cuts
July 01, 2024
Planet Labs layoffs are a hot topic on Monday as the satellite company prepares to cut 180 jobs, or 17% of its workforce, to reduce costs.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Cassava Sciences Cooperates With DOJ, SEC On Controversial Alzheimer's Drug Investigation
July 01, 2024
Cassava Sciences is cooperating with DOJ and SEC investigations involving its Alzheimer's drug simufilam. An internal committee is examining new SEC information, while the company advances its Phase 3...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Why Are Stocks Down Today?
July 01, 2024
Stocks are down today and investors wondering why have come to the right place as we know what's sending shares lower on Monday!
Via
InvestorPlace
SAVA Stock Alert: Former Cassava Science Advisor Charged With Fraud
July 01, 2024
SAVA stock is trading lower after a scientist behind Cassava's simufilam was charged with manipulating research data to justify his grants.
Via
InvestorPlace
Cassava Shares Are Down Over 30%: Here's Why
June 28, 2024
Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading significantly lower on Friday following the indictment of Hoau-Yan Wang, a tenured medical professor and advisor to the company, by a federal...
Via
Benzinga
Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich
June 27, 2024
These three biotech stocks to buy carry risks but may appeal to speculative investors with time and patience.
Via
InvestorPlace
(SAVA) - Analyzing Cassava Sciences's Short Interest
January 29, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
June 07, 2024
Via
Benzinga
GSK, Boston Beer And Other Big Stocks Moving Lower In Monday's Pre-Market Session
June 03, 2024
Via
Benzinga
SAVA Stock Earnings: Cassava Sciences Beats EPS for Q1 2024
May 10, 2024
SAVA stock results show that Cassava Sciences beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Biotech Stocks
April 30, 2024
As the stock market corrects, focusing on stable investments is crucial. This is why you should steer clear of these biotech stocks to avoid.
Via
InvestorPlace
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 12, 2024
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.
Via
Benzinga
Alzheimer's Drug Trial Results Questioned After 'Damning' FDA Inspection Report
March 11, 2024
The credibility of the clinical trial results for an experimental Alzheimer's drug has been called into question following a critical inspection report by the Food and Drug Administration.
Via
Benzinga
Exposures
Product Safety
Boeing, Oracle, Meta Platforms, Cassava Sciences, Tesla: Why These 5 Stocks Are On Investors' Radars Today
March 11, 2024
On Monday, the U.S. stock market presented a mixed performance. The Dow Jones index managed to turn higher, trading up by 0.12% to 38,769.66.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Exit Now! 3 Biotech Stocks to Sell in February 2024
February 21, 2024
These biotech stocks to sell represent incredibly risky bets, amidst the sector's volatility and looming economic unpredictability.
Via
InvestorPlace
Why Is WiMi Hologram Cloud (WIMI) Stock Up 22% Today?
February 08, 2024
WiMi Hologram Cloud stock is taking off on Thursday with speculative trading as it rallies alongside another Chinese hologram company.
Via
InvestorPlace
MicroCloud Hologram (HOLO) Stock Pops Another 10% in Speculative Rally
February 08, 2024
MicroCloud Hologram stock is taking off on Thursday as speculative traders continue to bet on HOLO shares following a recent rally.
Via
InvestorPlace
Cassava Sciences (SAVA) Stock Pops on Positive Results in Simufilam Trial
February 08, 2024
SAVA stock jumped 9% on Wednesday after Casava Sciences shared promising results of a clinical trial of its Alzheimer's treatment.
Via
InvestorPlace
Why Alzheimers-Drug Developer Cassava Sciences Stock Is Trending
February 07, 2024
The top-line results showed no decline in cognition scores in patients with mild Alzheimer's disease who received simufilam continuously for 24 months. "We're fighting Alzheimer's disease by testing...
Via
Benzinga
3 Biotech Stocks to Sell in January Before They Crash and Burn
January 25, 2024
The biotech industry is one of the most profitable though risky at the same time. Here are three biotech stocks to sell.
Via
InvestorPlace
Cassava Sciences Stock Continues Showing Rising Relative Strength
January 16, 2024
Cassava Sciences sees its Relative Strength Rating move into the elite 90-plus level.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.